The GI Surgeon and Gastroparesis
نویسندگان
چکیده
54 OVERVIEWS OF GASTROPARESIS Gastroparesis is characterized by delayed or impaired passage of gastric contents in the absence of mechanical obstruction. Symptoms vary and include nausea, vomiting, bloating, and abdominal pain. The symptoms and clinical presentation of gastroparesis is reflective of its pathogenesis, severity, and association with predisposing or associated conditions. Gastroparesis is related to a variety of underlying disorders. The most common causes of gastroparesis are diabetic, postsurgical and idiopathic (1). The true prevalence of gastroparesis is unknown. It is thought to occur in 20%–40% of patients with Type I diabetes mellitus and about 20% of patients with type II diabetes. Delayed gastric emptying occurs in about 25% of patients with functional dyspepsia, a disorder which includes a constellation of abdominal complaints that affects up to 20% of the U.S. population (2). Patients may develop gastroparesis after undergoing foregut surgery with or without vagotomy. One study noted that up to 8% of patients with postsurgical gastroparesis had developed symptoms after cholecystectomy (3). An increasing awareness is being paid to post-Nissen gastroparesis. Finally, the third most common The GI Surgeon and Gastroparesis GI MOTILITY, A SERIES FROM THE AMS, SERIES #9
منابع مشابه
The Association Between Fasting C-peptide and Gastrointestinal Symptoms of Gastroparesis in Type 2 Diabetic Patients
Background/Aims The relationship between C-peptide levels and gastrointestinal (GI) symptoms in type 2 diabetic patients is not clear. The purpose of this study is to examine the association between fasting C-peptide and GI symptoms of gastroparesis in type 2 diabetic patients. Methods We recruited 333 type 2 diabetic patients into the present study. All patients filled out questionnaires of ...
متن کاملDiabetic Gastroparesis: A Review of Medical Treatments
INTRODUCTION A ccording to 2007 data from the National Institute of Diabetes and Digestive and Kidney Diseases, 23.6 million people—7.8% of the US population have diabetes (1). Also, diabetes incurred an estimated expenditure of $174 billion in direct and indirect costs in 2007 (1). Part of this cost (estimated to be $22.9 billion in 2006) can be attributed to the treatment of diabetes-related ...
متن کاملTreatment of diabetic gastroparesis by high-frequency gastric electrical stimulation.
OBJECTIVE To investigate the long-term efficacy of high-frequency gastric electrical stimulation (GES) for treating diabetic gastroparesis. RESEARCH DESIGN AND METHODS This is a retrospective review of 48 adult diabetic patients with refractory gastroparesis who had a GES system implanted surgically and had follow-up evaluations at 6 and 12 months. The outcome measures were total symptom scor...
متن کاملNutritional therapy for the management of diabetic gastroparesis: clinical review
Diabetic gastroparesis (DGP), or slow emptying of the stomach, is a well-established complication of diabetes mellitus and is typically considered to occur in individuals with long-standing type 1 and type 2 diabetes mellitus. Clinical consequences of DGP include induction of gastrointestinal (GI) symptoms (early satiety, abdominal distension, reflux, stomach spasm, postprandial nausea, vomitin...
متن کاملDiagnostic Assessment of Diabetic Gastroparesis
Gastroparesis is characterized by a constellation of upper gastrointestinal (GI) symptoms in association with delayed gastric emptying (GE) in the absence of mechanical outlet obstruction from the stomach. Cardinal symptoms are nausea, vomiting, early satiety or postprandial fullness, bloating, and abdominal or epigastric pain (1). Gastric retention may be asymptomatic in some, possibly due to ...
متن کامل